Literature DB >> 27504606

Time trends in the incidence of oesophageal cancer in Asia: Variations across populations and histological types.

Shao-Hua Xie1, Jesper Lagergren2.   

Abstract

OBJECTIVE: We aimed to assess temporal trends in incidence rates of oesophageal cancer in Asian countries.
MATERIALS AND METHODS: Using data from the Cancer Incidence in Five Continents series, we examined the temporal trends in incidence rates of oesophageal cancer by population and histological type in seven Asian countries in 1988-2007. Age-period-cohort analyses estimated the overall annual percentage changes (net drifts) and their 95% confidence intervals (CIs) in incidence rates.
RESULTS: The age-standardised incidence rate of oesophageal cancer declined in most Asian populations, but remained relatively unchanged in Japan and Israel. The rate of oesophageal squamous cell carcinoma decreased in Hong Kong, Singapore and Israel, but was stable in Japan. The net drifts were statistically significant in men in Hong Kong (-3.4%, 95% CI: -6.1%, -0.7%) and in women in Singapore (-10.1%, 95% CI: -14.4%, -5.5%). The age-standardised incidence rates of oesophageal adenocarcinoma were below 2 and 0.5 per 100 000 in men and women, respectively, across all periods in the all registers containing valid data on histological type. The age-standardised incidence rate of oesophageal adenocarcinoma slightly increased in Japan, Singapore, and Israel, although the net drift was statistically significant only in Israeli men (4.9%, 95% CI: 0.8%, 9.1%).
CONCLUSION: The overall incidence rates of oesophageal cancer declined in most Asian countries, which is due to a decrease in oesophageal squamous cell carcinoma incidence. However, attention needs to be paid to a probable beginning of an increasing incidence of oesophageal adenocarcinoma in Asia.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Asia; Epidemiology; Incidence; Oesophageal cancer

Mesh:

Year:  2016        PMID: 27504606     DOI: 10.1016/j.canep.2016.08.002

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  8 in total

1.  Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030.

Authors:  Melina Arnold; Mathieu Laversanne; Linda Morris Brown; Susan S Devesa; Freddie Bray
Journal:  Am J Gastroenterol       Date:  2017-06-06       Impact factor: 10.864

2.  Inter-institutional variations regarding Barrett's esophagus diagnosis.

Authors:  Norihisa Ishimura; Mika Yuki; Takafumi Yuki; Yoshinori Komazawa; Yoshinori Kushiyama; Hirofumi Fujishiro; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  Esophagus       Date:  2018-07-28       Impact factor: 4.230

3.  Construction and Evaluation of a Risk Score Model for Autophagy-Related Genes in Esophageal Adenocarcinoma.

Authors:  Tianfu Xu; Yamei Yuan; Chenggong He; Kun Yang
Journal:  Med Sci Monit       Date:  2021-01-29

4.  Population-Based Incidence, Mortality, And Survival For Gastrointestinal Cancers During 2006-2016 In Wuhan, Central China.

Authors:  Yao Cheng; Jianhua Liu; Qing Liao; Xuejiao Hu; Hongyan Lv; Peiyan Ding; Shaofa Nie; Li Tan
Journal:  Cancer Manag Res       Date:  2019-10-29       Impact factor: 3.989

5.  Circumferential distribution and clinical characteristics of esophageal cancer in lower esophagus: differences related to histological subtype.

Authors:  Mayumi Okada; Norihisa Ishimura; Hironobu Mikami; Eiko Okimoto; Naoki Oshima; Youichi Miyaoka; Hirofumi Fujishiro; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  Esophagus       Date:  2018-08-25       Impact factor: 4.230

6.  Recombinant human endostatin plus paclitaxel/nedaplatin for recurrent or metastatic advanced esophageal squamous cell carcinoma: a prospective, single-arm, open-label, phase II study.

Authors:  Zhi-Qiang Wang; De-Shen Wang; Feng-Hua Wang; Chao Ren; Qiong Tan; Yu-Hong Li
Journal:  Invest New Drugs       Date:  2020-10-18       Impact factor: 3.850

7.  Global time trends in the incidence of esophageal squamous cell carcinoma.

Authors:  Qiao-Li Wang; Shao-Hua Xie; Karl Wahlin; Jesper Lagergren
Journal:  Clin Epidemiol       Date:  2018-06-19       Impact factor: 4.790

8.  Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis.

Authors:  Haiqi He; Nanzheng Chen; Yue Hou; Zhe Wang; Yong Zhang; Guangjian Zhang; Junke Fu
Journal:  Thorac Cancer       Date:  2020-03-10       Impact factor: 3.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.